PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 6,601,141 10.800% |
1,504,354 (+29.52%) |
Filing |
| 2024-04-10 12:58 pm Purchase |
2024-03-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 5,096,787 10.200% |
155,080 (+3.14%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 4,941,707 9.900% |
1,258,277 (+34.16%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 3,683,430 7.600% |
-1,175,197 (-24.19%) |
Filing |
| 2022-02-10 1:16 pm Purchase |
2022-01-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 4,858,627 10.400% |
711,708 (+17.16%) |
Filing |
| 2022-02-10 1:13 pm Purchase |
2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
PRICE T ROWE ASSOCIATES INC | 4,146,919 8.900% |
4,146,919 (New Position) |
Filing |